Diagnostic Testing for Sepsis: A Systematic Review of Economic Evaluations
- PMID: 35052904
- PMCID: PMC8773030
- DOI: 10.3390/antibiotics11010027
Diagnostic Testing for Sepsis: A Systematic Review of Economic Evaluations
Abstract
Introduction: Sepsis is a serious and expensive healthcare problem, when caused by a multidrug-resistant (MDR) bacteria mortality and costs increase. A reduction in the time until the start of treatment improves clinical results. The objective is to perform a systematic review of economic evaluations to analyze the cost-effectiveness of diagnostic methods in sepsis and to draw lessons on the methods used to incorporate antimicrobial resistance (AMR) in these studies.
Material and methods: the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed, and the Consolidated Health Economic Evaluation Reporting standards (CHEERS) checklist was used to extract the information from the texts.
Results: A total of 16 articles were found. A decision model was performed in 14. We found two ways to handle resistance while modelling: the test could identify infections caused by a resistant pathogen or resistance-related inputs, or outcomes were included (the incidence of AMR in sepsis patients, antibiotic use, and infection caused by resistant bacterial pathogens).
Conclusion: Using a diagnostic technique to detect sepsis early on is more cost-effective than standard care. Setting a direct relationship between the implementation of a testing strategy and the reduction of AMR cases, we made several assumptions about the efficacy of antibiotics and the length-of-stay of patients.
Keywords: AMR; antibiotics; diagnostic testing; sepsis; systematic review.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Efficiency of Diagnostic Testing for Helicobacter pylori Infections-A Systematic Review.Antibiotics (Basel). 2021 Jan 8;10(1):55. doi: 10.3390/antibiotics10010055. Antibiotics (Basel). 2021. PMID: 33430005 Free PMC article. Review.
-
Health economic evaluations of sepsis interventions in critically ill adult patients: a systematic review.J Intensive Care. 2020 Jan 8;8:5. doi: 10.1186/s40560-019-0412-2. eCollection 2020. J Intensive Care. 2020. PMID: 31934338 Free PMC article.
-
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.Value Health. 2013 Mar-Apr;16(2):231-50. doi: 10.1016/j.jval.2013.02.002. Value Health. 2013. PMID: 23538175
-
Systematic review of reporting quality of economic evaluations in plastic surgery based on the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.J Plast Reconstr Aesthet Surg. 2021 Oct;74(10):2458-2466. doi: 10.1016/j.bjps.2021.05.017. Epub 2021 Jun 21. J Plast Reconstr Aesthet Surg. 2021. PMID: 34217645
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
Cited by
-
Biomarkers in pulmonary infections: a clinical approach.Ann Intensive Care. 2024 Jul 17;14(1):113. doi: 10.1186/s13613-024-01323-0. Ann Intensive Care. 2024. PMID: 39020244 Free PMC article. Review.
References
-
- Rudd K.E., Johnson S.C., Agesa K.M., Shackelford K.A., Tsoi D., Kievlan D.R., Colombara D.V., Ikuta K.S., Kissoon N., Finfer S., et al. Global, regional, and national sepsis incidence and mortality, 1990–2017, analysis for the Global Burden of Disease Study. Lancet. 2020;395:200–211. doi: 10.1016/S0140-6736(19)32989-7. - DOI - PMC - PubMed
-
- Torio C.M., Moore B.J. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2013, Statistical Brief #204. Agency for Healthcare Research and Quality; Rockville, MD, USA: 2006. [(accessed on 24 November 2021)]. Available online: http://europepmc.org/abstract/MED/27359025. - PubMed
Publication types
LinkOut - more resources
Full Text Sources